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Background: The exact role of primary nanoparticle (NP) size and their degree of agglomeration in aerosols on the
determination of pulmonary effects is still poorly understood. Smaller NP are thought to have greater biological
reactivity, but their level of agglomeration in an aerosol may also have an impact on pulmonary response. The aim
of this study was to investigate the role of primary NP size and the agglomeration state in aerosols, using well-
characterized TiO2 NP, on their relative pulmonary toxicity, through inflammatory, cytotoxic and oxidative stress
effects in Fisher 344 male rats.
Methods: Three different sizes of TiO2 NP, i.e., 5, 10–30 or 50 nm, were inhaled as small (SA) (< 100 nm) or large
agglomerates (LA) (> 100 nm) at 20 mg/m3 for 6 hours.
Results: Compared to the controls, bronchoalveolar lavage fluids (BALF) showed that LA aerosols induced an acute
inflammatory response, characterized by a significant increase in the number of neutrophils, while SA aerosols
produced significant oxidative stress damages and cytotoxicity. Data also demonstrate that for an agglomeration
state smaller than 100 nm, the 5 nm particles caused a significant increase in cytotoxic effects compared to
controls (assessed by an increase in LDH activity), while oxidative damage measured by 8-isoprostane concentration
was less when compared to 10–30 and 50 nm particles. In both SA and LA aerosols, the 10–30 nm TiO2 NP size
induced the most pronounced pro-inflammatory effects compared to controls.
Conclusions: Overall, this study showed that initial NP size and agglomeration state are key determinants of nano-TiO2
lung inflammatory reaction, cytotoxic and oxidative stress induced effects.
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Oxidative stressBackground
In recent decades, nanoparticles (NP) (< 100 nm) have
attracted the increased attention of the industrial sector
due to their unique physico-chemical properties and nu-
merous applications. Indeed, compared to their larger-sized
counterparts, NP have improved and distinctive surface
characteristics which are considered as the building blocks
of nanotechnology. This fast developing field is expected to
generate by 2014 more than 10 million jobs related to this
technology [1]. Thus, an increasing number of workers are* Correspondence: truchon.ginette@irsst.qc.ca
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reproduction in any medium, provided the orgoing to be handling NP during the production and dis-
posal of several consumer products [2]. Reliable testing
strategies to investigate possible health effects caused by
NP exposure are therefore urgently needed. Risk assess-
ment is based on exposure expressed in terms of dosimetry
and toxicological data [3]. Hence, research studies should
examine the characteristics of NP or aerosols that deter-
mine their ability to cause deleterious effects. Currently, the
best metric, such as mass, surface area, number or size dis-
tribution, to measure NP in order to evaluate risk and pre-
vent the development of occupational diseases is still a
matter of debate [3].
Several toxicological studies have addressed the micro
versus the nano size effect. This has indicated at equivalentd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Noël et al. Particle and Fibre Toxicology 2013, 10:48 Page 2 of 18
http://www.particleandfibretoxicology.com/content/10/1/48mass concentration that agglomerated NP produce greater
pulmonary inflammation responses than micron size parti-
cles [4-8]. However, few studies have investigated in vivo
the size-dependent effects of NP [9-11]. As NP (< 100 nm)
size decreases, it is expected that the percentage of atoms
and active sites at the surface, as well as the structural im-
perfections, increase significantly [12,13]. In addition, it has
previously been shown that metal oxide particles less than
30 nm in size, had enhanced interfacial reactivity [14,15].
Correspondingly, the biological reactivity of smaller NP is
expected to be higher than that of larger NP [16]. More-
over, it is at approximately 20 nm that the highest relative
deposition efficiency of NP in the alveolar region occurs
[17,18]. This suggests that NP of different initial sizes could
produce different biological responses [16,19].
TiO2 is a substance that is manufactured at a large scale,
either as crude, fine or ultrafine powder. Given its import-
ant industrial production, several countries use TiO2 as a
reference nanomaterial in research and in the assessment
of workplace exposures [20-23]. However, to this day there
is still limited consistent toxicological data and similarly
limited epidemiological studies related to occupational ex-
posures to this chemical [24-29]. This puts the emphasis
on the need for more research on TiO2 NP.
Our research group and other studies have previously
reported that agglomeration is a process occurring in nano-
TiO2 aerosol production [9,19,30-34]. Using different
methods to generate NP aerosols in laboratory studies, we
have shown that a given TiO2 NP can agglomerate in differ-
ent sizes and structures [33]. This observation is relevant
and valuable for toxicological assessment since there is in-
creasing evidence that aerosol characteristics can modulate
NP interaction with biological systems [9,18,35-38]. Indeed,
agglomeration of NP has multiple influences on dose char-
acteristics and on their pulmonary toxicity and kinetics. It
can affect: 1- the number concentration in the aerosol; 2-
the deposition site in the respiratory tract; 3- the possibility
of detection and subsequent phagocytosis by alveolar mac-
rophages; 4- the fate in lung tissue and translocation to
other extra-pulmonary compartments; and 5- the size, dens-
ity, shape and structure of the resulting particle, being either
loose or compact. Furthermore, once deposited in the re-
spiratory tract, NP can interact with biological material (e.g.,
pulmonary surfactant, macromolecules and proteins), which
can also have an impact by increasing, slowing or preventing
the degree of agglomeration in the physiological environ-
ment [36,39,40]. Taken together, it is highly relevant to
characterize and consider the agglomeration state of NP,
particularly metal oxides, in nanotoxicological studies.
We have previously reported that rats exposed by in-
halation to small agglomerates (< 100 nm) of 5 nm TiO2
showed greater cytotoxic and oxidative stress responses
than rats exposed to larger agglomerates (> 100 nm) of
the same NP, which induced a slight inflammatoryreaction [41]. This suggested that biological responses to
TiO2 might depend on the dimension and concentration
of the NP agglomerates. These results are in line with the
current hypothetical mechanisms of NP pulmonary tox-
icity, based on the inflammation and oxidative stress
paradigm [17,42-44].
In inhalation studies, establishing the effect of primary
NP size involves considering the size of the agglomerates,
and only few studies have addressed this issue. In the early
90’s, several influential studies [4,5,45,46] were conducted
and showed differences in toxicologically relevant responses
and translocation of NP versus submicrometer particles ad-
ministered as submicrometer-sized aerosols. A recent study
conducted by Balasubramanian et al. [47] showed in rats
that primary NP size of inhaled gold NP influenced the
whole-body biodistribution. Gold NP of 7 or 20 nm pri-
mary sizes were generated into aerosols of similar number
concentration and size distribution. This showed that the
agglomerates of the 7 nm NP were distributed in more or-
gans than the 20 nm NP and that macrophage clearance
was more effective for agglomerates of larger primary size.
In a study by Pauluhn [11], rats exposed to aluminum oxide
NP aerosols showed a clearance half-time which increase
with decreased primary NP size (10 nm - 840 nm in aero-
sols and 40 nm – 660 nm in aerosols), while the inflamma-
tory response appeared to be determined by the size of the
agglomerates. In a study conducted by Grassian et al. [9],
mice exposed to 7 mg/m3 of 5 nm TiO2 NP (120 nm in
aerosol) or 21 nm NP (139 nm in aerosol) showed that the
latter was slightly, but significantly more toxic than the
smaller NP. These authors suggested that the difference in
the structure of the agglomerates, which was compact for
the 5 nm TiO2 versus loose for the 21 nm particles, could
be partly responsible for the results. Collectively, these in-
halation nanotoxicology studies suggest that smaller ini-
tial NP size could distribute in more extra-pulmonary
organs and might not always induce enhanced lung in-
flammatory reactions when compared to larger nano-
metric counterparts.
The exact role of primary NP size and their degree of
agglomeration in aerosols in the determination of pul-
monary effects is still poorly understood. Indeed, smaller
NP are thought to have greater biological reactivity, but
the level to which these NP agglomerate in aerosols may
also have an impact on the pulmonary response. More-
over, NP of different primary sizes could possibly bundle
in agglomerates of various dimensions, shapes and struc-
tures in aerosols, which can also influence their pulmon-
ary toxicity and kinetics. Thus, the primary particle size
and agglomeration state of NP can be of significance in
toxicity and partly responsible for the distinct effects in-
duced in lungs. To our knowledge, no previous study has
addressed both factors simultaneously, i.e., the size-
dependent effect of NP while also comparing the influence
Table 1 TiO2 NP powder characterization assessed by
transmission electron microscopy (TEM) and X-ray
diffraction (XRD)
Parameters Methods Results
5 nm Morphology TEM Spherical: > 97%
n = 375 Rod-shape: < 3%
Crystal phase XRD Anatase: > 97%
(volume)
Rutile: < 3%





10-30 nm Morphology TEM Spherical
n = 330 Crystal phase XRD Anatase: 100%
(volume)
No rutile detected





50 nm Morphology TEM Spherical: > 80%
n = 302 Rod-shape: < 20%
Crystal phase XRD Anatase: > 80%
(volume)
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factors on the mechanism of toxicity will provide import-
ant knowledge for NP risk assessment.
The aim of this study was to investigate the role of pri-
mary NP size and agglomeration state in aerosols using
well-characterized TiO2 NP and to compare their relative
pulmonary toxicity, through inflammatory, cytotoxic and
oxidative stress effects in rats. For this purpose, we used
three different sizes of TiO2 NP, i.e., 5, 10–30 or 50 nm in-
haled as small (< 100 nm) or large agglomerates (> 100 nm)
at a concentration of 20 mg/m3.
Results
Characterization of initial NP powders
In this paper, we define nanoparticle (NP) as particle whose
nominal diameter (geometric, mobility, aerodynamic,
projected surface or other) is less than 100 nm [48]. The
characterization of the three nano-TiO2 powders (as re-
ceived by the manufacturers) which were used to produce
the aerosols along with transmission electron microscopy
(TEM) images, are presented in Table 1. X-ray spectromet-
ric analysis (EDS) analysis showed that all powders were
made of TiO2. The size distribution of the NP present in
the powders was established by measuring the diameter of
over 300 particles by TEM. These results showed that the
median diameter of the NP present in the powder labeled
by the manufacturer as 5 nm was 10.6 nm, while it was
18.2 nm and 34.8 nm for the 10–30 nm and 50 nm pow-
ders, respectively. The analysis also showed that the size
distributions of the three nano-powders slightly overlapped
(data not shown). In addition, TEM analysis showed that,
in the case of the 5 and 50 nm powders, particles had a
spherical or rod-shaped morphology, while the 10–30 nm
powder, showed only spherical particles. Analysis by X-ray
diffraction (XRD) revealed that the 5 and 10–30 nm pow-
ders were predominantly in the anatase form (> 97%), while
the 50 nm powder showed a slightly higher presence of the
rutile form (< 20%).
Measurement and characterization of NP aerosols
Throughout this article, we refer to small agglomerate
(SA) aerosols as mainly composed of agglomerates with a
size smaller than 100 nm and large agglomerate (LA) aero-
sols as essentially composed of agglomerates larger than
100 nm. Aerosol’s characterization data carried out with
the ELPI, DustTrak and gravimetric measurements are
presented in Table 2. Cumulative size distributions based
on number concentration measured with the ELPI are
shown in Figure 1. Three values were used to estimate the
number size distributions, namely the first quartile (D25),
the midpoint (D50) or the median aerodynamic diameter
based on the number concentration (NMAD), and the
third quartile (D75). These results show that for each TiO2
NP, the size distributions obtained for SA and LA aerosolsare different (Table 2 and Figure 1). The targeted exposure
concentration was 20 mg/m3 for all exposed groups and
the concentrations gravimetrically measured were between
18.8 and 22.0 mg/m3. As measured with the ELPI, the total
particle number was higher in the aerosols composed of
SA compared to the aerosols composed of LA.
Figure 2 shows representative TEM images of particles
from the aerosols composed of SA or LA. For the same
initial particle size, TEM images (12 000-×) allowed the
observation of qualitative differences in the size, shape
Table 2 Measurements and characterization of the NP aerosols
Experimental groups
Parameters Control 5 nm SAa 5 nm LAb 10-30 nm SA 10-30 nm LA 50 nm SA 50 nm LA
Average mass concentrationc (mg/m3) 0.05 18.77 19.30 22.04 21.99 21.38 21.94














Total particle numbere (/cm3) - 3 159 758 308 098 1 808 939 374 225 1 320 239 280 379
D25
e,f (nm) - 29 156 28 128 35 135
NMAD* or D50
e,f (nm) - 48 369 65 255 85 321
GSDg - 3.1 2.2 3.3 2.6 3.2 2.6
D75
e,f (nm) - 124 575 183 686 305 783
Fraction of NP agglomerates <100
nme (%)
- 71 16 63 18 54 19
a Aerosol composed of small agglomerates.
b Aerosol composed of large agglomerates.
c Average mass concentration determined by weight measurements.
d Min and max concentration determined by a DustTrak.
e Measurements made with the ELPI.
f Aerodynamic diameters for which 25% (D25), 50% (D50 or NMAD) or 75% (D75) of the particles in the aerosol are smaller than this value, based on number
concentration. D75 – D25 is the interquartile range and represents the size distribution where we find 50% of the particles.
g GSD: geometric standard deviation.
*NMAD: number median aerodynamic diameter.
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(Figure 2). Indeed, SA aerosols were mostly composed of
small compact agglomerates, while LA aerosols had lar-
ger agglomerates with void space. Higher magnification
(120 000-×) allowed the observation of irregularly shaped
small agglomerates (Figure 2).
Pulmonary deposition
Using the polydisperse diameter interquartile ranges
presented in Table 2, the estimated respiratory tract de-
position fraction of NP agglomerates was computed with
the MPPD model for LA and SA aerosols. These resultsFigure 1 Cumulative distributions based on number concentration of
number concentration measured with the ELPI. For each aerosol 5 thirty-mare presented in Figure 3 and indicate that pulmonary
deposition is different for the two types of aerosols.
Rat pulmonary response
A transient increase in leukocytes from BALF is a natural
lung defense mechanism following deposition of inhaled
particles. In this manner, BALF cytology analysis from rats
exposed to SA aerosols showed increases in total cell count,
number of macrophages and neutrophils compared to the
control group. Increases were slightly but statistically sig-
nificant (p < 0.05) for total cell count and number of mac-
rophages in the 5 and 10–30 nm groups compared to thethe NP aerosols. NP aerosols cumulative size distributions based on
inute samples were collected every hour of the experiment.
Figure 2 NP aerosol agglomerate structure observed by transmission electron microscopy. Air samples were collected on pre-carbon
coated Formvar copper grids glued onto 25-mm polycarbonate filters. Characterization (shape, agglomeration degree and structure) of the nano-
aerosols was performed by TEM.
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also showed increases in total cell count, number of macro-
phages and neutrophils compared to the control group. Re-
sults were significant (p < 0.05) for total cell count, number
of macrophages and neutrophils in the 10–30 and 50 nm
groups compared to the controls (Table 3, Figure 4).
The profiles of inflammatory cytokines are shown in
Figure 5. Thirteen of the 29 cytokines analyzed in the assay
showed ≥ 1.2-fold increases compared to the control group
(CCL5, CXCL7, TIMP-1, TNF-α, L-selectin, MIP-1α, MIP-
3α, IL-1β, IL-6, CINC-3, CXCL1, sICAM, INF-γ). Notice-
ably, the 10–30 nm LA aerosol showed a profile where all of
the 13 cytokines were increased compared to the controls.
8-isoprostane, a marker of oxidative stress, showed a statis-
tically significant increase for all SA aerosols compared to
the controls or respective LA aerosols (Figure 6). There were
also significant differences between the three SA aerosols.
For the 5 nm SA aerosol the 8-isoprostane concentration
was significantly (p < 0.05) lower compared to the 10–30
and 50 nm SA aerosols (Figure 6). For LDH activity, only the
results for the 5 nm SA aerosol were statistically (p < 0.05)
different from the controls (Figure 6). There was also a sig-
nificant (p < 0.05) difference between the 5 nm SA and all
LA aerosols (Figure 6).Representative cell morphology of the BALF cytoprepa-
rations from the control and exposed rats are shown in
Figure 7. The control group showed typical BAL cells. For
all nano-TiO2 exposed groups, the majority of the cells
(macrophages, neutrophils and lymphocytes) were also
typical, although giant cells (macrophages) and fragmented
nucleus macrophages were observed (Figure 7).
Estimation of NP endocytosis by macrophages
Figure 7 shows representative images of BAL macro-
phages with (arrows) or without phagocytized NP ag-
glomerates. All groups exposed to the LA aerosols had
79 ± 2% (standard error on the mean, SEM) of macro-
phages that contained nano-TiO2 agglomerates, whereas
for the SA aerosols, it was 57 ± 3% (SEM) (Table 3). For
each primary NP size, a significant difference was ob-
served for the percentage of particle-laden macrophages
between the LA and SA aerosols (Table 3).
Lung histopathology
Figures 8 and 9 show images of haematoxylin and eosin
stained lungs. The control group did not show any signs
of inflammation. Noteworthy, the cellular influx ob-
served were partial since these lungs were also used for
Figure 3 Computed fractional deposition of NP agglomerates in
the rat respiratory tract. Estimated deposition fraction for the aerosols at
20 mg/m3 composed of SA or LA modeled for multiple diameters. TB =
tracheobronchial; P = pulmonary. Functional residual capacity (FRC)
volume 4 ml; head volume: 0.42 ml; nasal breathing route; tidal volume
2.1 ml; breathing frequency 110/min and inspiratory fraction 0.1.
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lung tissue responses to nano-TiO2 were different in in-
tensity compared to the controls, except for the 50 nm
SA group (Figure 8). The lungs of rats exposed to 5 and
10–30 nm SA aerosols as well as rats exposed to 10–30
and 50 nm LA aerosols showed more leukocyte infiltra-
tion compared to the control group (Figure 8). This is
consistent with the cytological analysis (Table 3, Figure 4)
and is considered to represent a normal macrophage
clearance response. Figure 9, which is representative of
all groups, shows TiO2 NP-laden macrophages in the 5
nm SA aerosol group.Table 3 BALF cytology and estimation of NP endocytosis by m
Experimenta
Cell type Control 5 nm SA 5 nm L
Total cellsa 2.36±0.46 4.32±0.27* 4.02±0.6
Lymphocytesb 4.16±0.60 2.15±0.37 8.08±1.9
Neutrophilsc 0.23±0.05 1.18±0.19 1.18±0.3
Macrophagesa 2.30±0.45 4.18±0.27* 3.82±0.5
Estimation of endocytosis (%)d — 53±3.8ŧ 78±1.3
a number of cells x 106 ± standard error on the mean (SEM); b number of cells x 10
phagocytosis by macrophages. Mean values (n = 6 rats per group) significantly diffe
ŧp<0.05 significantly different from LA aerosol of the same primary NP size.Discussion
Since TiO2 NP tends to agglomerate in aerosols [9,32-34],
establishing the effect of these NP involves considering
the primary particle size and that of the agglomerates [9].
The agglomeration state of NP influences the site of par-
ticle deposition in the respiratory tract and affects lung
clearance mechanisms, including endocytosis [9,19,45-53].
In general, the size distribution of a NP aerosol is com-
posed of a less (< 100 nm) and highly (> 100 nm) agglom-
erated fraction, with the percentage varying from one
aerosol to another. The less agglomerated fraction, for
which the size of the agglomerates is closer to the size of
the primary NP, could possibly induce effects related to
their interaction with lung tissue and epithelial cells at the
site of pulmonary deposition. These small particles are
also more readily available for translocation to the lymph
nodes or bloodstream [17]. Larger agglomerates (> 100
nm) are thought to be more easily detected and removed
by the lung macrophages [41,54-57].
In our study, the cellular pulmonary response observed
for all exposed groups denoted by the increases in leuko-
cytes from BALF compared to the controls (Table 3,
Figure 4) could be considered as a normal immediate re-
sponse to particle aggression [58]. The increase in the
number of macrophages and neutrophils is thought to con-
tribute to particle removal. Indeed, previous studies have
shown that following inhalation of nano-TiO2 this type of
response is temporary and resolves rapidly [9,19,30,32].
Hence, after an acute exposure, this could be a defense
mechanism [59].
NP aerosol characterization
For the LA aerosols, we observed that the 5 nm TiO2 pro-
duced larger agglomerates than the 10–30 and 50 nm parti-
cles (Table 2). This result could be partly explained by the
fact that as particle size decreases, the attractive force per
unit mass increases, which favors agglomeration [60]. In-
deed, small particles that coagulate into agglomerates larger
than superior-sized counterparts is a common finding pre-
viously described in numerous inhalation studies, including
ones using nano-TiO2 [11,30,38,45,61].acrophages following inhalation exposure
l groups
A 10-30 nm SA 10-30 nm LA 50 nm SA 50 nm LA
3 4.41±0.40* 5.38±0.45** 3.01±0.36 4.82±0.36**
7 4.57±0.82 7.02±2.67 2.85±0.49 4.34±1.37
4 1.26±0.16 1.47±0.41* 0.84±0.18 1.78±0.22**
9 4.24±0.39* 5.16±0.42** 2.90±0.35 4.60±0.36**
53±1.9ŧ 78±2.9 65±1.9ŧ 83±1.3
4 ± SEM; c number of cells x 105 ± SEM; d estimation of the extend of NP
rent from controls (ANOVA followed by a Tukey’s test) *p<0.05, **p<0.01,
Figure 4 BALF cytology analyzed by the cytospin method. Data were expressed as fold increases of exposed groups compared to controls.
Bars represent the mean value and the standard error of the mean obtained for 6 rats in each exposure group. Statistical procedures: ANOVA
followed by a Tukey’s test. *Mean value is statistically different from control level p < 0.05.
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As shown in Figure 3, the estimated pulmonary deposition
was different for the LA and SA aerosols. Also, given their
different agglomeration states (Table 2), it can be assumed,
as described by Oberdörster et al. [17] as well as Geiser
and Kreyling [62], that the penetration of these aerosols
into the various regions of the respiratory tract is different.
Considering their size distribution characteristics (D25 =
128 nm to D75 = 783 nm; Table 2), particles of the LA
aerosols could be more easily detected by immune system
cells, including alveolar macrophages (Table 3, Figures 7
and 8). Indeed, the estimation of NP endocytosis showed
for all LA aerosols that 79 ± 2% of macrophages contains
nano-TiO2 agglomerates (Table 3). In our study, activation
of macrophages following phagocytosis of large NP ag-
glomerates (Figure 7) is supported by a slight but signifi-
cant increase in the total cell count, and number of
macrophages and neutrophils compared to controls for
two out of the three LA aerosols (10–30 and 50 nm)
(Table 3 and Figure 4). However, the 50 nm LA aerosol did
not increase the level of inflammatory cytokines, whereas
interferon γ (INF-γ), chemokine C-X-C motif ligand 7
(CXCL7), interleukine-6 (IL-6), macrophage inflammatory
protein 1α (MIP-1α) and MIP-3α were increased for the
10–30 nm LA aerosol when compared to the controls.
These cytokines are produced by activated macrophages
and act in host defense by promoting phagocytosis,
resulting in chemotaxis, inflammatory cell recruitment andactivation at the site of injury [63-65]. In particular, MIP-1α
activates granulocytes (neutrophils, eosinophils, basophils)
which can lead to acute neutrophilic inflammation [63-65].
The detection and phagocytosis of these agglomerates by
macrophages can prevent their interaction with lung cells
and tissue [41,45,66,67]. This is also supported by our
results, where no cytotoxicity or oxidative stress effects,
evaluated through LDH activity and 8-isoprostane concen-
tration, were observed for these LA aerosols (Figure 6).
LDH is a cytoplasmic enzyme that is released by dead cells
and is therefore a suitable marker of cell cytotoxicity, while
8-isoprostane is a biomarker of lipid peroxidation and thus
an indicator of oxidative stress effects [68,69].
An increase in the number of neutrophils supports the
presence of an inflammatory reaction [12,32,39,65]. Thus,
a mild significant inflammatory (p < 0.05) response was ob-
served following the 10–30 and 50 nm LA aerosols expo-
sures. These results are consistent with the common finding
of various nanotoxicological studies on the increases in the
number of neutrophils following agglomerated nano-TiO2
exposures [9,19,32,41,45,70-72]. Previous studies have also
observed that inhalation of agglomerated nano-TiO2, in
mice and rats, caused slight inflammatory responses and
long-term pulmonary inflammation [9,19,30,32,72-75].
SA aerosols
For the 5 and 10–30 nm SA aerosols, the cytological ana-
lysis showed a statistically significant increase in total cell
Figure 5 Relative levels of BALF pro-inflammatory cytokines. BALF pro-inflammatory cytokines were expressed as fold increases of exposed
groups compared to controls. Samples from all rats of the same exposure group were pooled together. The ratio for each cytokine was
calculated as described in materials and methods. Results with ratios ≥1.2 were considered to represent a slight inflammation. (A) Aerosols with a
primary NP size of 5 nm. (B) Aerosols with a primary NP size of 10–30 nm. (C) Aerosols with a primary particle size of 50 nm.
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Figure 7 Representative cell morphology from BALF cytopreparations of rats. Optical microscopy (magnification 400-x) of cells
cytopreparation collected in BALF of sham, controls (exposed to compressed air) and TiO2 NP exposed rats. For all TiO2 exposed groups, the
images show giant foamy macrophages and the distribution of macrophages containing phagocytized TiO2 NP (arrows). Scale bar = 50 μm.
Figure 6 BALF cytotoxicity (LDH) and oxidative stress (8-isoprostane) markers. Data were expressed as fold increases of exposed groups
compared to controls. Bars represent the mean value and the standard error on the mean obtained for 6 rats in each exposure group. LDH assay
for each rat was done in triplicate and 8-isoprostane was in duplicate. Statistical procedures: ANOVA followed by a Tukey’s test. * Mean value is
statistically different from control level p < 0.05; ** Mean value is statistically different from control level and 10–30; 50 nm SA aerosols p < 0.05;
ŧ Mean value is statistically different from all LA aerosol levels p < 0.05.
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Figure 8 Optical microscopy images (100-x) of lung tissue sections. Morphological assessments of lung tissue stained with haematoxylin and
eosin of sham (A), control (exposed to compressed air) and TiO2 NP exposed rats by means of inhalation for 6 hours. Responses to nano-TiO2 (C to G)
were different in intensity compared to the controls (B), except for the 50 nm SA group (H). The lungs of rats exposed to 5 and 10–30 nm SA aerosols
(D and F) as well as rats exposed to 10–30 and 50 nm LA aerosols (E and G) showed more leukocyte infiltration compared to the control group (B).
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Figure 9 Optical microscopy images (400-x) of lung tissue sections. (A) Lung of control rat exposed to compressed air. (B) Lung of a rat
exposed to small agglomerates of 5 nm NP. This figure demonstrates TiO2 NP engulfed by alveolar macrophages (arrows).
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Qualitatively, these results are consistent with the histo-
pathological findings (Figure 8). The estimation of NP
endocytosis showed that all SA aerosols had 57 ± 3% of
macrophages containing nano-TiO2 agglomerates (Table 3).
Despite the NMAD values that were below 100 nm for
these aerosols, the D75 values ranged from 124 to 305 nm.
Thus, the agglomerated (> 100 nm) fraction, which was en-
countered for 29 to 46% of these aerosols could explain the
NP endocytosis observed. Nonetheless, for each primary
NP size, a significant difference was observed for the per-
centage of particle-laden macrophages between LA and SA
aerosols. Also, increases in the relative levels of CXCL7 and
MIP-3α were observed in all SA aerosols, while it was also
the case for the tissue inhibitor matrix proteinase 1 (TIMP-
1), a glycoprotein involved in the degradation of the extra-
cellular matrix, for the 10–30 nm SA aerosol. Considering
the size distributions of the SA aerosols (D25 = 28 nm to
D75 = 305 nm; Table 2) and as shown with the estimation
of NP endocytosis, it can be assumed that these aerosols
were not as well detected and phagocytized by alveolar
macrophages as the LA aerosols. Thus, increased NP inter-
action with biological materials (lung cells and tissue) may
have occurred compared to the LA aerosols and could be
expressed as cytotoxicity and oxidative stress effects. In our
study, statistically significant increases were observed in
LDH activity and 8-isoprostane concentration for the 5 nm
SA aerosol compared to the controls and its respective LA
aerosol, while only 8-isoprostane was significantly increased
for the 10–30 and 50 nm SA aerosols (Figure 6). There-
fore, overall, the results for the SA aerosols indicate
clear trends of NP interaction with lung cells and tissue
through oxidative stress damage and suggestive slight
cytotoxic effects (Figure 6).
Effect of the agglomeration state
Overall, these results confirm, at a higher mass concentra-
tion, what we had previously shown at 7 mg/m3 [41],namely that an acute inhalation of nano-TiO2 with two
distinct agglomeration states, smaller or larger than 100
nm, induced different mild pulmonary effects. An acute
inflammatory response measured by an increase in the
number of neutrophils was induced by exposure to two
out of three LA (> 100 nm) aerosols, while significant oxi-
dative stress effects were observed after exposures to all of
the SA (< 100 nm) aerosols. With respect to hazard identi-
fication, our results indicate that even though LA aerosols
induced an acute inflammatory response, which is revers-
ible according to the literature [9,19,32,45,70,72], it cannot
be concluded that these aerosols induce toxicity through
the same mechanisms as SA aerosols, which showed clear
oxidative stress damage in BALF.
Effect of primary nanoparticle size
For the three initial TiO2 NP sizes, we observed only one
significant difference within the smaller than 100 nm ag-
glomeration state aerosols. The significant difference was
observed between the 5 nm and the two other SA aerosols
for the 8-isoprostane concentration (Figure 6). This sug-
gests that the larger 10–30 and 50 nm particles induced
more lipid peroxidation and oxidative stress damage than
the smaller 5 nm particles. Numerous inhalation studies
have previously demonstrated that translocation of various
type of NP, including TiO2, to extrapulmonary compart-
ments occurred for small agglomerated NP (average diam-
eter < 80 nm) in aerosols [37,76-83]. Collectively, these
studies indicate that the penetration efficiency of NP
through cellular membranes increases as the NP size de-
creases and that the translocation time increases with par-
ticle size [84-86]. Thus, in our study, the smaller size of the
5 nm particles (D50 = 48 nm in aerosol) would facilitate
their possible and rapid translocation from the lung epithe-
lial cells, thereby reducing their availability and time to
cause cellular membrane lipid peroxidation at the NP - cell
interface. The larger size of the 10–30 and 50 nm particles
(D50 = 65 and 85 nm in aerosols, respectively) may on the
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over a longer period of time, resulting in increased inter-
action of NP with the cellular membranes, which generates
oxidative stress through membranolytic effects (Figure 6).
We observed that the LDH activity for the SA aerosols
compared to controls was only significant for the 5 nm par-
ticles (Figure 6). This same aerosol also showed a lower in-
crease in 8-isoprostane concentration than the other two
SA aerosols (Figure 6). This could possibly be explained by
the higher cytotoxicity response observed in these animals.
Indeed, LDH is an enzyme that leaks from damaged cells as
a sign of membrane integrity lost [87] and as previously
mentioned, is a suitable marker of cell death, particularly by
necrosis. It could also be considered as evidence of NP
penetration into cells [88]. NP penetration into cells leading
to interactions with intracellular components is size-
dependent [85,86]. Thus, the lower cytotoxicity observed
for the larger NP (10–30 and 50 nm) could possibly be due
to their less efficient penetration into cells. Interestingly,
our data suggest that membrane damage by lipid peroxida-
tion at the NP – cell membrane interface might not be the
primary cause of cytotoxicity. Thus, the size-dependent ef-
fect of nano-TiO2 observed in our study in the smaller than
100 nm agglomeration state is supported by the literature.
Also, these results are in line with Paulhun’s study [11] that
reported that the clearance kinetics of NP was more
dependent on their initial particle size.
50 nm TiO2 NP
In addition, for the SA aerosols, there may be a few rea-
sons that explain the lack of cellular and histopatho-
logical changes with the 50 nm group compared to the 5
and 10–30 nm groups (Figures 4 and 8). First, consider-
ing the NP powder characterization, approximately 20%
of the crystal phase of the 50 nm powder was in the rutile
form, while it was 3% or less for the two other powders
(Table 1). It has already been reported that the rutile form
of TiO2 NP is less toxic than the anatase crystal phase
[38,40,89-92]. Thus, in the less than 100 nm agglomeration
state, the presence of the rutile phase in the 50 nm powder
may be partly responsible for the lower cellular toxicity ob-
served. At equal mass concentration, as the NP size de-
creases, the surface area per mass unit increases and leads
to high surface to volume ratios, giving smaller NP en-
hanced surface reactivity [12]. Studies have also shown that
the surface adsorption and reactivity of smaller than 10 nm
TiO2 NP were enhanced relatively to larger NP [19,93].
Hence, the size effect of the initial 5 nm particle size (D50 =
48 nm in aerosol), which would be more toxic than the 50
nm particles (D50 = 85 nm in aerosol), may also contribute
to the cytological effects observed for the SA aerosols. Also,
for these three aerosols, the total particle number concen-
tration was elevated (Table 2). However, the 50 nm SA
aerosol had the lowest total particle number concentrationby a factor of 2.4 and 1.4 compared to the 5 and 10–30 nm
aerosols, respectively. Due to their small size, NP mainly
contribute to number concentrations in aerosols and, to a
much lesser degree, to mass concentration [94,95]. For
identical masses, a larger number of NP can occupy the
same space, and thus, in theory, increase the interactions
with biological material [12,96]. Thus, all of these factors
may also contribute to the toxicological results observed
for the 50 nm SA aerosol.
Primary NP size-dependant effect
Overall, these results show that within a less than 100
nm agglomeration state, there may be a primary particle
size-dependent effect of nano-TiO2. Even though the
10–30 and 50 nm particles induced significantly higher
oxidative stress and pro-inflammatory damage than the
5 nm particles, it cannot be directly concluded that these
larger TiO2 NP are more toxic. Our data, in line with
the current literature, show that the smaller 5 nm parti-
cles may potentially pose greater health risks by causing
more cytotoxicity through necrosis.
It is noteworthy that a limitation to our study can be at-
tributed to the fact that only data 16 hours after a 6-hour
exposure were collected. Therefore, conclusions on pro-
longed inflammation and cytotoxicity cannot be drawn
from these data. However, our results indicate that for an
acute exposure the 10–30 nm particles induced significant
increases in the total cell count and number of macro-
phages in both the SA and LA aerosols, while the number
of neutrophils was significantly increased in the LA aerosol
(Table 3, Figure 4), which also showed the highest fold in-
creases in pro-inflammatory cytokine (Figure 5). Moreover,
qualitatively comparing the agglomerate structure of the
LA aerosols (Figure 2) we noticed that the 10–30 nm parti-
cles agglomerated into loose structures with more void
open spaces. The possibility of agglomeration and de-
agglomeration of NP in physiological environments still
remains an open question [3,9,38,45,47]. However, if de-
agglomeration was to occur once deposited in the lungs,
the loose agglomerate structure is thought to be more eas-
ily de-agglomerated [9]. Moreover, when considering the
geometry of similar agglomerates size, the loose type
structure has a higher surface available to interact with
biological materials and could hence increase their toxicity
compared to the compact agglomerates. Therefore, the
NP agglomerates structure may also play a role in toxicity.
Overall, of the three NP sizes, the 10–30 nm TiO2 NP
seemed to induce the most pronounced pro-inflammatory
effects. These results are consistent with Grassian et al. [9]
inhalation study in mice at 7 mg/m3 where it was con-
cluded, solely based on the inflammatory cell response,
that the 21 nm nano-TiO2 particles (139 nm in aerosol)
were slightly, but significantly more toxic than the 5 nm
ones (120 nm in aerosol). Interestingly, the highest relative
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approximately 20 nm [17,18].
Conclusions
In summary, the results of this study suggest that the ini-
tial NP size and the agglomeration state are key determi-
nants of nano-TiO2 lung inflammatory reaction, cytotoxic
and oxidative stress induced effects. Acute exposure to
20 mg/m3 of nano-TiO2 in rats inhaled as LA aerosols
induced an acute inflammatory response, noted by an
increase in the number of neutrophils, while SA aerosols
also produced oxidative stress damage and cytotoxicity in
BALF. These results indicate that the toxicity modes of
nano-TiO2 are different when inhaled as two distinct ag-
glomeration states, smaller or larger than 100 nm, and
that within a smaller than 100 nm agglomeration state,
there may be a primary particle size-dependent effect of
nano-TiO2. The 5 nm particles caused increased cytotoxic
effects while the oxidative damage was milder when com-
pared to 10–30 and 50 nm particles. This suggests that
smaller NP can cause cytotoxicity by penetrating more
easily into cells and thereby reducing their interaction
with the cellular membrane at the NP – cell interface,
resulting in decreased oxidative stress effects. In addition,
the most pronounced pro-inflammatory effects were
induced by the 10–30 nm TiO2 NP, which is also the size
having the highest relative deposition efficiency in the
alveolar region.
The overall observed responses for the LA and SA
aerosols as well as the primary particle size effect in the
less than 100 nm agglomeration state must beFigure 10 Experimental set-up for the generation of small agglomerate
produce aerosols essentially composed of small NP agglomerates. ELPI: electrinvestigated in future studies incorporating multiple
doses, time points and nano-TiO2 of different crystal
phases, as well as systemic and translocation effects to
better elucidate the impact of these factors on the NP
kinetics and mechanism of toxicity.
Methods
General experimental study design
Animal inhalation exposures were performed in a
cubic stainless steel 500-L inhalation chamber (Unifab,
Kalamazoo, MI) adapted for nose-only. Ports were placed
on a single wall of the inhalation chamber so that only the
nose of the animal was exposed to the aerosol (see
Figure 10). Six groups of rats (n = 6 per group) were
exposed to TiO2 aerosols for 6 hours; one control group
(n = 6) was exposed to clean air for the same duration.
One sham group (n = 6) was not exposed and remained
housed in the animal facility. No anesthetic treatment was
given to the rats prior to the exposures. The aerosols were
composed of either 5, 10–30 or 50 nm primary particle
size TiO2. Each primary particle size of TiO2 was gener-
ated in aerosols with two distinct size distributions
consisting of large (> 100 nm) or small agglomerates
(< 100 nm) at mass concentrations of 20 mg/m3. Small
agglomerate (SA) aerosols were produced by a wet gener-
ation method and large agglomerate (LA) aerosols by a
dry powder dispersion technique. The animals were
sacrificed 16 hours after the end of the exposure period,
and bronchoalveolar lavages (BAL) were performed to de-
termine cellular markers of pulmonary toxicity. Lungs
were also fixed for histopathology observations.aerosols. Experimental set-up using three nebulizers in parallel to
ical low pressure impactor; HEPA filter: high-efficiency particulate air filter.
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Anatase TiO2 with average particle sizes of 5 nm (Stock#
5420MR) and 10–30 nm (Stock# 5420HT), specific area
of 200–220 m2/g and near spherical morphologies were
purchased from Nanostructured and Amorphous Mate-
rials Inc. (Texas, USA). Anatase 50 nm TiO2 (MK-TiO2-
A050) was purchased from MKnano (Ontario, Canada).
All the NP were stored in a desiccator placed in a fume
hood prior to use. These NP were characterized by TEM
(field emission gun (FEG) JEOL JEM-2100F), EDS and
XRD (Philips, model: X’Pert, Lelyweg, The Netherlands).
These characterization methods were previously des-
cribed in Noël et al. [33].
Animals
Forty-eight 8-week-old male CDF (F344)/CrlBR (Charles
River Breeding Laboratories, St. Constant, Québec, Canada)
rats with an average weight on the day of sacrifice of 164 ±
12 g were housed at the animal care facilities of the
Université de Montréal. The rats were placed two per cage
and had access to water and food ad libitum. The animals
were exposed to a 12-h/12-h day/night cycle from 6:00 am
to 6:00 pm. The animals were acclimatized to the inhalation
chamber for a period of six days prior to NP exposure.
Weight gain for each animal was recorded daily. The re-
search project was approved by the Université de Montréal’s
Ethics Committee on Animal Experiments.
Generation of TiO2 NP aerosols
All aerosols were generated using compressed air that
first passed though a Donaldson high-efficiency indus-
trial filter equipped with a coalescing filter (Donaldson
DFSP, Series Model-DF 0070 ZU, Ultra-Filter Superplus,
Donaldson Company, Inc., Norcross, GA, USA). The
average temperature and relative humidity in the inhal-
ation chamber were 23.07 ± 0.72°C and 39.3 ± 16.6%
RH. A fan mixed the air in the inhalation chamber. For
all exposures, the total air flow entering the chamber
was between 3.6 and 4.5 m3 per hour.
Generation of small agglomerate aerosols – Nebulization
of TiO2 NP
Aerosols composed of small agglomerates were generated
using a Lovelace-type nebulizer (In-Tox products, Albu-
querque, New Mexico) placed in parallel with two Delavan
siphon spray nebulizers (Part number 30609–2 used with
an adapter, part number DLN 17147, Delavan Spray Tech-
nologies, Goodrich Corporation, Montréal, Canada) (Fig-
ure 10). We used three nebulizers in parallel to reach the
targeted concentration of 20 mg/m3. Indeed, the type and
number of nebulizers used constitute important factors
contributing to the ultrafine size distribution of the aero-
sols [33]. The high air flow that passes through the
Delavan nebulizer, helps to reduce the size of the dropletsand by this means the use of two Delavan allowed the
NMAD to be lowered by increasing the number of small
NP agglomerates in the aerosol [33]. A 7 g/L (for the 5
nm experiment) or a 5 g/L (for the 10–30 nm and 50 nm
experiments) NP suspension in distilled water (Milli-Q
reference A+ system, water purification system with total
oxidizable carbon indicator, Millipore Corporation) was
filtered on Whatman 41 filter paper (Piscataway, NJ, USA)
to remove large agglomerates, and sonicated for 10 mi-
nutes (Bransonic tabletop ultrasonic cleaner, model 5510,
Branson, Danbury, CT, USA). This suspension was poured
into the Delavan devices. Since the filtered suspension did
not allow the targeted mass concentration to be reached,
2.5 g (for the 5 nm experiment) or 1.5 g (for the 10 – 30
and 50 nm experiments) of the TiO2 powder was placed
in the Lovelace-type nebulizer prior to the addition of the
original suspension (350 ml) to completely fill the device.
This new suspension was not sonicated. The suspension
was agitated for the entire generation period using mag-
netic stirring plates placed under each nebulizer. The flow
rate used for each nebulizer was 5, 25 and 10–13 L/min
for the Lovelace-type nebulizer, the first and second
Delavan, respectively. The pressure applied to each
nebulizer was between 30 and 35 psi. Dual-element
heating tapes (624 watts, 120 VAC, Cole-Parmer, Canada)
wrapped around a copper tube were used to dry the aero-
sol, prior to its dispersion in the inhalation chamber. The
flow rate of the dilution air was 25–30 L/min and served
to reduce the relative humidity in the chamber created by
the water vapor content of the aerosol. No charge
neutralization was performed on these aerosols.
Generation of large agglomerate aerosols –Powder
dispersion of TiO2 NP
The aerosols composed of large agglomerates were pro-
duced using a Fluidized Bed 3400A device (TSI Inc.,
Shoreview, MN, USA). The exposure concentration for
each primary particle size was achieved by adjusting the
various feed rates of the Fluidized Bed. The pressure ap-
plied to this instrument was between 33 and 38 psi. No
charge neutralization was performed.
TiO2 aerosol sampling and characterization
TiO2 NP aerosols sampling and characterization methods
have been described in detail elsewhere [33]. Briefly, air
samples were collected throughout the experiment on cas-
settes (Sure Seal, SKC Inc.) using 37-mm polyvinyl chloride
(PVC) filters at a flow rate of 4 L/min to subsequently de-
termine the average mass concentration by gravimetric ana-
lysis. The mass concentrations were followed and adjusted
in real time using a Model 8520 Dust Trak Aerosol Moni-
tor (TSI Inc., Shoreview, MN, USA) previously calibrated
with TiO2 by comparison with the gravimetric method. Air
samples were also collected at a flow rate of 1 L/minute on
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mm polycarbonate filters. The glue used was a current
cyanoacrylate (Loctite superglue gel, Henkel, Boucherville,
Canada). The sampling durations were 2.5 and 5 min for all
of the aerosols. Characterization (shape, agglomeration
degree and structure) of the aerosols sampled on these
grids was performed by TEM (Philips CM200 equipped
with a digital camera: Corel Corp. AMTV600 2K×2K,
80 kV). Numbers and particle size distributions were
monitored in real time with an electrical low pressure
impactor (ELPI) (Dekati Ltd., Tampere, Finland) which
was operated at a flow rate of 10 L/minute in the filter
stage configuration. The sintered impaction substrates
were oiled to prevent or reduce particle bounce. Cumu-
lative size distributions based on number concentration
were monitored through 5 thirty-minute samples col-
lected every hour of the experiment. The ELPI was also
used to determine the number median aerodynamic
diameter NMAD and the geometric standard deviation
(GSD). Air samples were all collected in the area of the
inhalation chamber corresponding to the breathing
zone of the animals.
Pulmonary deposition modeling
The rats’ airway particle dosimetry was estimated using the
Multiple-Path Particle Dosimetry Model (MPPD) (software
version 2.11, Applied Research Associates Inc., Albuquer-
que, NM, USA). The respiratory tract deposition of NP ag-
glomerates was estimated for LA and SA aerosols.
Bronchoalveolar lavages
The animals were anaesthetized with isoflurane and
sacrificed by exsanguination. BAL fluids (BALF) were col-
lected with 0.9% saline. The BAL techniques were previ-
ously described elsewhere [97]. Briefly, five 5-ml washes
were pooled and placed on ice. The collected BALF were
centrifuged at 929 × g at a temperature of 4°C for 10 mi-
nutes. After centrifugation, the supernatant was removed
and frozen at −80°C. These supernatants were aliquoted
and used for cytotoxicity and oxidative stress analysis.
Multiple freeze–thaw cycle was avoided to prevent loss of
enzyme activity. These supernatants were used for cyto-
toxicity and oxidative stress analysis. The cells were
resuspended in 500 μl of saline. 100-μl aliquots were fixed
with formalin for cell count (1:1). The lungs were fixed in
situ with buffered formalin.
Analysis of the pulmonary response
Cell suspensions were mixed 1:1 with methylene blue to de-
termine the total cell counts using a hemacytometer. The
cytospin cell staining method using Hema 3 solutions
(Fisher Diagnostics cat. nos. 122-911A, 122-911B and 122-
911C) were used to obtain differential cell counts for
lymphocytes, neutrophils and macrophages. Slides wereobserved using a photonic microscope with a magnification
of 400-× (Leica DM 1000). Cytotoxicity was evaluated by
determining levels of lactate dehydrogenase (LDH) activity
(Cytotoxicity Detection Kit for LDH, Roche Applied Sci-
ence, Laval, QC, Canada). The oxidative stress response
was evaluated by measuring 8-isoprostane concentration
(8-isoprostane EIA kit, Cayman Chemical, Ann Arbor, MI,
USA). Cytokines in BAL were analyzed using Rat Cytokine
Array Panel A (R & D Systems, Minneapolis, MN, USA) to
determine the relative levels of 29 cytokines (CINC-1,
CINC-2α/β, CINC-3, CNTF, Fractalkine (CX3CL1), GM-
CSF, sICAM-1 (CD54), IFN-γ, IL-1α, IL-1β, IL-1ra. IL-2,
IL-3, IL-4, IL-6, IL-10, IL-13, IL-17, IP-10 (CXCL10), LIX,
L-Selectin (CD62L/LECAM-1), MIG (CXCL9), MIP-1α
(CCL3), MIP-3α (CCL20), RANTES (CCL5), Thymus Che-
mokine (CXCL7), TIMP-1, TNF-α, VEGF). To perform this
assay, samples from the same exposure group were pooled
together. Data from this assay were analyzed by chemilu-
minescent signals of cytokines/chemokines present in the
BALF and were detected on Kodak X OMAT-RA film, as
described in Ratthe et al. [98] and Gonçalves et al. [98].
Results were reported as described in Gonçalves et al. [99].
Briefly, cytokines with ≥ 1.2-fold increased compared to the
control group were considered to represent a slight inflam-
mation. All assays were performed as specified by the re-
spective manufacturers.
Estimation of NP endocytosis by macrophages
The cytospin slides were used to visually estimate the
extent of NP phagocytosis by counting 200 macro-
phages for the presence or absence of NP agglomerates
inside the cytoplasm. In this way, the percentage of
particle-laden macrophages was established. Slides
were observed using a photonic microscope (Leica
DM 1000).
Lung histopathology
The lungs were fixed in situ with buffered formalin. Sub-
sequently, caudal right lobe lung sections were cut into
thin slices (3 to 5 mm thick) using a clean scalpel. Samples
were placed inside histology cassettes before processing.
Wax infiltration (Sakura Tissue Tek VIP E150) was
achieved following dehydration through 3 alcohol baths
(70, 85 and 90%) and cleared through 3 toluene baths. For
embedding, tissue was oriented inside a mold filled with
hot paraffin (Embedding station ESBE EC350). Tissue sec-
tioning (4 μm thick) was done with a microtome (Micro-
tome LEICA RM2255). Sections were then colored using
haematoxylin and eosin staining standard protocol. Images
were acquired using an Olympus BX51 optical microscope.
Statistical procedures
BALF cytology, pulmonary cytotoxicity, oxidative stress
markers as well as NP endocytosis by macrophages were
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nificance was achieved when p < 0.05. Statistical analyses
were performed using the Statistical Package for the So-
cial Sciences (SPSS, version 17.0, SPSS Inc.).
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